This prospective, open-label pilot/feasibility study of 10 youth with T1D is to evaluate glycemic and metabolic changes taking place with a very low carbohydrate diet.
First, to evaluate the feasibility of following each type of VLCD (high protein or high fat), participants will follow a standard carbohydrate diet for 2 weeks, followed by a 1 week transition to a VLCD, and then follow the a high protein VLCD for 2 weeks followed by a high fat VLCD for 2 weeks. The study will consist of 4 in person or virtual visits which will take place over \~7 weeks. All participants will be initially studied for 2 weeks while ingesting a standard diet recommended by the American Diabetes Association, followed by a 1-week transition to a VLCD, and followed by 2 weeks on each type of VLCD (high protein, high fat). During the first (baseline) period fasting β-hydroxybutyrate levels will be measured 2-3 times per week. During the VLCD study periods, fasting β-hydroxybutyrate levels will be measured daily in the morning using a blood ketone meter; insulin doses will be collected using insulin pump downloads and continuous glucose monitoring (CGM) profiles will be used to assess glycemic excursions on each diet, as well as the time in hypo-, eu- and hyperglycemic ranges. The purpose of this study is to examine changes in sensor glucose levels, basal and bolus insulin doses, and metabolic factors following implementation of a very low carbohydrate diet (VLCD). Sensor-derived time glucose ranges will serve as a surrogate marker of hemoglobin A1c given the short duration of the study. Safety measures of the diet will also be assessed, including daily fasting ketone levels. The first hypothesis of the study is that use of a VLCD with strict monitoring of ketosis will reduce glycemic variability and increase time in target range, defined as 70-180 mg/dL by reducing the time in the hyperglycemic (\>180 mg/dL) and hypoglycemic ranges (\<70 mg/dL). Decreased carbohydrate intake will lead to less postprandial hyperglycemia. Lower insulin doses for meals and snacks as a result of decreased carbohydrate intake will lessen postprandial hypoglycemia as well.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
6
A very low carbohydrate diet (VLCD), is defined as limiting carbohydrate intake to 11% of total daily caloric intake.
Yale-New Haven Hospital
New Haven, Connecticut, United States
Percentage of Time in Target Range of 70-180 mg/dL.
The target range is 70 mg/dL - 180 mg/dL based on sensor-derived glucose levels. The outcome is reflected as the percentage of time spent in this range during the time frame.
Time frame: 2 weeks per intervention, up to 7 weeks
Percentage of Time Spent > 180 mg/dL to 250 mg/dl
The percent of time spent \> 180 mg/dL to 250 mg/dl based on sensor-derived glucose values. Reflected is the percentage of time spent in the range of 181-250 mg/dL.
Time frame: 2 weeks per intervention, up to 7 weeks
Percent Time Spent > 250 mg/dL Based on Sensor-derived Glucose Values
The percent of time spent \> 250 mg/dL based on sensor-derived glucose values. Presented is the percentage of time people spent in the range.
Time frame: 2 weeks per intervention, up to 7 weeks
Percent of Time Spent > = 55 to < 70 mg/dL Based on Sensor-derived Glucose Values
The percent of time spent \> = 55 to \< 70 mg/dL based on sensor-derived glucose values. Reflected is the percentage of time within range.
Time frame: 2 weeks per intervention, up to 7 weeks
Percent Time Spent < 55 mg/dL Based on Sensor-derived Glucose Values
The percent of time spent \< 55 mg/dL based on sensor-derived glucose values during the timeframe. Presented is the percentage of overall time spent in the specified range.
Time frame: 2 weeks per intervention, up to 7 weeks
Total Daily Insulin Dose
The total daily insulin dose will be defined as the average total daily insulin dose will be calculated over 2 weeks. Values represent the mean units/kg/day for the 2 week period.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: 2 weeks per intervention, up to 7 weeks
Average Sensor Glucose Level
The average sensor glucose level recorded by the continuous glucose monitor over the 2 week dietary period in mg/dL.
Time frame: 2 weeks per intervention, up to 7 weeks